Agilon Health, Inc. (AGL)
89.77
-2.83
(-3.06%)
USD |
NYSE |
Sep 11, 16:00
89.64
-0.12
(-0.14%)
After-Hours: 20:00
Agilon Health Enterprise Value : 1.283B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.283B |
| September 10, 2026 | 1.330B |
| September 09, 2026 | 1.347B |
| September 08, 2026 | 1.310B |
| September 04, 2026 | 1.262B |
| September 03, 2026 | 1.228B |
| September 02, 2026 | 1.243B |
| September 01, 2026 | 1.244B |
| August 31, 2026 | 1.251B |
| August 28, 2026 | 1.329B |
| August 27, 2026 | 1.357B |
| August 26, 2026 | 1.383B |
| August 25, 2026 | 1.389B |
| August 24, 2026 | 1.350B |
| August 21, 2026 | 1.397B |
| August 20, 2026 | 1.333B |
| August 19, 2026 | 1.348B |
| August 18, 2026 | 1.377B |
| August 17, 2026 | 1.402B |
| August 14, 2026 | 1.403B |
| August 13, 2026 | 1.268B |
| August 12, 2026 | 1.224B |
| August 11, 2026 | 1.226B |
| August 10, 2026 | 1.401B |
| August 07, 2026 | 1.379B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.234B |
| August 05, 2026 | 1.586B |
| August 04, 2026 | 1.367B |
| August 03, 2026 | 1.356B |
| July 31, 2026 | 1.314B |
| July 30, 2026 | 1.400B |
| July 29, 2026 | 1.331B |
| July 28, 2026 | 1.440B |
| July 27, 2026 | 1.428B |
| July 24, 2026 | 1.421B |
| July 23, 2026 | 1.459B |
| July 22, 2026 | 1.788B |
| July 21, 2026 | 1.887B |
| July 20, 2026 | 1.826B |
| July 17, 2026 | 1.956B |
| July 16, 2026 | 1.811B |
| July 15, 2026 | 1.862B |
| July 14, 2026 | 1.834B |
| July 13, 2026 | 1.721B |
| July 10, 2026 | 1.704B |
| July 09, 2026 | 1.718B |
| July 08, 2026 | 1.653B |
| July 07, 2026 | 1.580B |
| July 06, 2026 | 1.582B |
| July 02, 2026 | 1.639B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 2.215B |
| Starling Oncology, Inc. | 683.28M |
| Nakamoto, Inc. | 292.19M |
| American Oncology Network, Inc. | -- |
| Tenet Healthcare Corp. | 36.35B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 17.96M |
| Revenue (Quarterly) | 1.495B |
| Total Expenses (Quarterly) | 1.477B |
| EPS Diluted (Quarterly) | 1.043 |
| Gross Profit Margin (Quarterly) | 6.71% |
| Profit Margin (Quarterly) | 1.20% |
| Earnings Yield | -16.93% |
| Normalized Earnings Yield | -14.35 |